Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $15.57
- 52-wk high
- $19.25
- High
- $16.18
- 52-wk low
- $10.34
- Low
- $15.34
- Prev close
- $15.30
Smart money
Earnings
Earnings came in 55.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $73.5M | $77.1M | $77.7M | $83.2M |
| Cost of what it sold | $8.5M | $8.5M | $6.5M | $6.6M |
| Gross profit | $65.0M | $68.6M | $71.2M | $76.7M |
| What it spent | ||||
| Research and development | $8.4M | $10.9M | $7.5M | $13.1M |
| Sales and admin | $25.6M | $28.5M | $21.7M | $23.5M |
| Other operating costs | $1.2M | -$4.0M | $606.0K | -$6.2M |
| Total operating expenses | $35.2M | $35.4M | $29.8M | $30.3M |
| What was left | ||||
| Operating profit | $29.7M | $33.2M | $41.4M | $46.3M |
| Interest on debt | $1.1M | $6.5M | $1.0M | $948.0K |
| Profit before tax | $32.0M | $35.7M | $43.9M | $48.8M |
| Tax | $411.0K | -$175.1M | $9.6M | $11.4M |
| Net profit | $31.6M | $210.8M | $34.4M | $37.4M |
| EBITDA | $36.8M | $47.1M | $49.8M | $54.6M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
(AUPH) Risk Channels and Responsive Allocation
Leans bullishAug 15Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Recommendation of "Hold" from Brokerages
NeutralAug 9Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by Wall Street Zen to Buy
NeutralAug 8